医学
紫杉烷
乳腺癌
蒽环类
养生
阶段(地层学)
内科学
肿瘤科
化疗
指南
癌症
新辅助治疗
病理
生物
古生物学
作者
J Wang,Bingqiu Xiu,Rong Guo,Bosui Yang,Qin Zhang,Yonghui Su,L Li,Weiru Ji,Y Y Zhang,A‐Yong Cao,Zhimin Shao,Jiong Wu
出处
期刊:PubMed
[National Institutes of Health]
日期:2020-11-23
卷期号:42 (11): 931-936
被引量:7
标识
DOI:10.3760/cma.j.cn112152-20190924-00623
摘要
Neoadjuvant therapy for breast cancer is widely performed in most hospitals in China, while the proportion of neoadjuvant treatment in patients with operable breast cancer is still low. Meanwhile, the idea of achieving de-escalation operation through neoadjuvant treatment is not promoted and the therapeutic evaluation method of neoadjuvant treatment needs further studies to improve.
科研通智能强力驱动
Strongly Powered by AbleSci AI